Ads
related to: monoclonal antibody
Search results
New COVID-19 'FLiRT' Variants Are The Most Dominant In The U.S.
Women's Health via AOL· 4 hours agoThose who are more vulnerable to getting sick during a spring or summer surge may benefit from the...
New tool may help identify infants at high risk for poor RSV outcomes
Center for Infectious Disease Research and Policy· 4 hours agoThe tool may also help address any family hesitancy about giving the RSV monoclonal antibody by...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoTremfya is an interleukin (IL)-23 and CD64-inhibiting monoclonal antibody. It was first approved as...
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOX 59 Indianapolis· 59 minutes agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced ...
Glenmark to market BeiGene’s oncology medicines in India
Pharmaceutical Technology via Yahoo Finance· 10 hours agoTislelizumab is a humanised immunoglobulin G4 anti-programmed cell death protein 1 monoclonal ...
Once-Promising Drug for Idiopathic Pulmonary Fibrosis Fails in Phase III Trial
MedPage Today· 2 days agoThe fully human monoclonal antibody pamrevlumab failed to improve lung function among patients with...
Immunotherapy before and after surgery may improve lung cancer survival rates
MedicalNewsToday via AOL· 2 hours agoA recent study found that providing immunotherapy pre- and post-surgery helps improve survival rates...
GigaGen doses first subject in Phase I advanced solid tumour trial
Clinical Trials Arena via Yahoo Finance· 13 hours agoAdditionally, the study will establish the maximum tolerated dose (MTD) and recommended Phase II...
Mirikizumab Shows Promise for Moderate to Severe Crohn's
Medscape· 2 days agoAlready approved for ulcerative colitis, the monoclonal antibody mirikizumab met study endpoints for...
AstraZeneca’s fasenra asthma drug shows promise for COPD treatment
BioPharma-Reporter· 9 hours agoThis approval extends Fasenra's availability to over 80 countries, including the US, EU, and Japan....